Table 2 Articles that only evaluate the global function related to the donor site

24.

Bachelet et al. [47]

AB, aggressive fibromatosis, giant mandibular cyst, trauma, mucoepidermoid carcinoma, osteochemonecrosis, first arch syndrome

n = 54 median age 31

CG

No physical and functional complications

25.

Li et al. [13]

Adenocarcinoma, melanoma, mucoepidermoid cyst, sarcoma, adenoid cystic carcinoma, carcinoma not otherwise specified, esthesioneuroblastoma, no residual tumor

n = 154 median age 57–63

FFF, ICFF

Clawing of the great toe, ankle stiffness

26.

Maben et al. [41]

SCC, SpCC, AB, OF, KCOT

n = 20 age 17–60

FFF

No problems with walking or problems of different degrees, difficulties in activities of daily living to different degree, change in gait pattern

27.

Rendenbach et al. [39]

Malignomas of the head and neck region

n = 19 age 31–74

FFF

Significant reduction of jump height and decrease in AOFAS-Score, no significant differences between limbs in maximum strength and peak power, One-Leg Balance Testing and motions in the mediolateral direction, increase in motions in the anteroposterior direction in both limbs, a significant deficit in sagittal motion in the ankle joint, reported big toe contracture, persistent numbness at the donor site, limitations of everyday activities and subjective gait insecurity

28.

Rendenbach et al. [14]

AB, SCC, osteonecrosis, myxofibroma, mucoepidermoid carcinoma

n = 14 age 22–87

ICFF

No significant differences before and after surgery on the Esslinger Fitness Index, chair raising test, jumping tests, balance testing, a significant reduction all ranges of motion in the lumbar spine and hip joint except for dorsal extension, occasional limitations of everyday activities (getting up from sitting or lying down, doing sports)

29.

Xu et al. [40]

SCC, AB, OM, KCOT

n = 30 age 20–66

FFF

Decrease in ankle isokinetic test, results of the EMG test categorized as 3 types, changes in plantar pressure distribution, reported weakness of the limb

30.

Zheng et al. [29]

Benign tumor, OS

n = 4 age 12–32

ICFF

No gait disturbances associated with the donor site